» Articles » PMID: 36292069

Point-of-Care Echocardiographic Characteristics of COVID-19 Patients with Pulmonary Embolism

Abstract

Introduction: Thrombotic complications, such as pulmonary embolism, are common in COVID-19 patients. Point-of-care ultrasound is a highly recommended tool for orientation in critically ill patients with suspected or confirmed complications.

Methods: An observational study was conducted on 32 consecutive patients with confirmed pulmonary embolism and COVID-19 infection treated in the Intensive Care Unit of the University Hospital Medical Center "Bežanijska kosa", Belgrade, Serbia, between April 2021 and March 2022. Predictors of the need for oxygen support were determined, while point-of-care echocardiographic parameters and various anamnestic, laboratory, and clinically significant parameters were correlated with the Pulmonary Embolism Severity Index (PESI) score.

Results: More than two-thirds of patients in our study had PE symptoms present at hospital admission (68.8%). The majority of patients had segmental pulmonary embolism (48.4%), with high to very high PESI score values in 31.3% of patients. Pneumonia was present in 68.8% of the study population. The PESI score was negatively correlated with diastolic blood pressure and SaO2 at the time of PE diagnosis, LV ejection fraction, and PVAT. A positive correlation was found between the PESI score, maximum CRP, and D-dimer at the time of PTE diagnosis. A larger right ventricular diameter was associated with a greater need for oxygen support.

Conclusion: Point-of-care echocardiography is a valuable tool for the risk assessment of COVID-19 patients with pulmonary embolism. Right ventricular size stood out as a significant marker of disease severity.

Citing Articles

Point-of-care ultrasound use in COVID-19: a narrative review.

Chua M, Boon Y, Yeoh C, Li Z, Goh C, Kuan W Ann Transl Med. 2024; 12(1):13.

PMID: 38304913 PMC: 10777239. DOI: 10.21037/atm-23-1403.


Ultrasound during the COVID-19 Pandemic: A Global Approach.

Lombardi A, De Luca M, Fabiani D, Sabatella F, Del Giudice C, Caputo A J Clin Med. 2023; 12(3).

PMID: 36769702 PMC: 9918296. DOI: 10.3390/jcm12031057.

References
1.
Ng J, Liang Z, Choong A . The incidence of pulmonary thromboembolism in COVID-19 patients admitted to the intensive care unit: a meta-analysis and meta-regression of observational studies. J Intensive Care. 2021; 9(1):20. PMC: 7897892. DOI: 10.1186/s40560-021-00535-x. View

2.
Tang N, Li D, Wang X, Sun Z . Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020; 18(4):844-847. PMC: 7166509. DOI: 10.1111/jth.14768. View

3.
Poor H . Pulmonary Thrombosis and Thromboembolism in COVID-19. Chest. 2021; 160(4):1471-1480. PMC: 8213519. DOI: 10.1016/j.chest.2021.06.016. View

4.
Halaby R, Popma C, Cohen A, Chi G, Zacarkim M, Romero G . D-Dimer elevation and adverse outcomes. J Thromb Thrombolysis. 2014; 39(1):55-9. PMC: 4300425. DOI: 10.1007/s11239-014-1101-6. View

5.
Popadic V, Klasnja S, Milic N, Rajovic N, Aleksic A, Milenkovic M . Predictors of Mortality in Critically Ill COVID-19 Patients Demanding High Oxygen Flow: A Thin Line between Inflammation, Cytokine Storm, and Coagulopathy. Oxid Med Cell Longev. 2021; 2021:6648199. PMC: 8081622. DOI: 10.1155/2021/6648199. View